Procept Biorobotics Corp
PRCT58.930USD
+1.890+3.31%
Cierre 07/17, 16:00（ET）Cotizaciones retrasadas 15 min
3.26BCap. mercado
PérdidaP/E TTM
Más Datos de Procept Biorobotics Corp Compañía
PROCEPT BioRobotics Corporation is a commercial-stage surgical robotics company. The Company is focused on advancing patient care by developing transformative solutions in urology. It develops, manufactures, and sells the AQUABEAM Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery with an initial focus on treating benign prostatic hyperplasia (BPH). The Company's proprietary AQUABEAM Robotic System delivers Aquablation therapy, which combines real-time, multidimensional imaging, personalized treatment planning, automated robotics and heat-free waterjet ablation for targeted and rapid removal of prostate tissue. Aquablation therapy delivers effective, safe and durable outcomes for males suffering from lower urinary tract symptoms (LUTS), due to BPH, which are independent of prostate size and shape or surgeon experience.
Información de la empresa
Símbolo de cotizaciónPRCT
Nombre de la empresaProcept Biorobotics Corp
Fecha de salida a bolsaSep 15, 2021
Fundada en2021
Director ejecutivoDr. Reza Zadno, Ph.D.
Número de empleados756
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 15
Dirección150 Baytech Drive
CiudadSAN JOSE
Bolsa de valoresNASDAQ Global Market Consolidated
PaísUnited States of America
Código postal95134
Teléfono16502329832
Sitio Webhttps://www.procept-biorobotics.com/
Símbolo de cotizaciónPRCT
Fecha de salida a bolsaSep 15, 2021
Fundada en2021
Ejecutivos de la empresa
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
843.16K
+0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Dr. Reza Zadno, Ph.D.
Dr. Reza Zadno, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.97K
+26.35%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%
Ms. Elisabeth Little
Ms. Elisabeth Little
Independent Director
Independent Director
11.02K
--
Mr. Larry L. Wood
Mr. Larry L. Wood
Independent Director
Independent Director
5.97K
+34.72%
Thomas M. Prescott
Thomas M. Prescott
Independent Chairman of the Board
Independent Chairman of the Board
3.90K
+65.22%
Ms. Alaleh Azarkhish Nouri
Ms. Alaleh Azarkhish Nouri
Executive Vice President, Chief Legal Officer, Corporate Secretary
Executive Vice President, Chief Legal Officer, Corporate Secretary
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Frederic H. (Fred) Moll, M.D.
Dr. Frederic H. (Fred) Moll, M.D.
Independent Director
Independent Director
843.16K
+0.18%
Mr. Taylor C. Harris
Mr. Taylor C. Harris
Independent Director
Independent Director
134.25K
+1.16%
Mr. Kevin Waters
Mr. Kevin Waters
Executive Vice President, Chief Financial Officer
Executive Vice President, Chief Financial Officer
66.61K
-6.22%
Dr. Reza Zadno, Ph.D.
Dr. Reza Zadno, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
65.97K
+26.35%
Mr. Hisham Shiblaq
Mr. Hisham Shiblaq
Executive Vice President, Chief Commercial Officer
Executive Vice President, Chief Commercial Officer
18.05K
--
Ms. Mary Garrett
Ms. Mary Garrett
Independent Director
Independent Director
14.38K
+11.97%
Desglose de ingresos
Divisa: USDActualizado: dom., 6 de jul
Divisa: USDActualizado: dom., 6 de jul
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
Por negocioUSD
Nombre
Ganancia
Proporción
Hand pieces and other consumables
42.49M
61.43%
System sales and rentals
22.54M
32.59%
Service
4.13M
5.98%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
60.29M
87.18%
Outside United States
8.87M
12.82%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
Hand pieces and other consumables
42.49M
61.43%
System sales and rentals
22.54M
32.59%
Service
4.13M
5.98%
Estadísticas de accionistas
Actualizado: dom., 8 de jun
Actualizado: dom., 8 de jun
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
14.67%
The Vanguard Group, Inc.
9.25%
BlackRock Institutional Trust Company, N.A.
6.24%
AllianceBernstein L.P.
3.87%
T. Rowe Price Investment Management, Inc.
2.56%
Other
63.41%
Accionistas
Accionistas
Proporción
Fidelity Management & Research Company LLC
14.67%
The Vanguard Group, Inc.
9.25%
BlackRock Institutional Trust Company, N.A.
6.24%
AllianceBernstein L.P.
3.87%
T. Rowe Price Investment Management, Inc.
2.56%
Other
63.41%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
45.36%
Investment Advisor/Hedge Fund
34.67%
Hedge Fund
7.57%
Individual Investor
4.25%
Research Firm
3.31%
Bank and Trust
1.10%
Pension Fund
0.73%
Venture Capital
0.66%
Family Office
0.08%
Other
2.26%
Participación institucional
Actualizado: mar., 1 de jul
Actualizado: mar., 1 de jul
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2025Q2
528
53.99M
97.59%
-2.22M
2025Q1
539
53.99M
97.68%
-2.82M
2024Q4
499
53.70M
99.42%
+875.53K
2024Q3
449
49.13M
94.16%
-1.41M
2024Q2
393
47.17M
91.61%
-2.29M
2024Q1
345
48.36M
95.04%
-4.45M
2023Q4
326
47.80M
94.81%
-4.63M
2023Q3
322
46.77M
93.30%
+2.15M
2023Q2
298
38.23M
84.44%
-1.74M
2023Q1
275
35.37M
78.88%
-3.41M
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Fidelity Management & Research Company LLC
8.12M
14.67%
+55.63K
+0.69%
Mar 31, 2025
The Vanguard Group, Inc.
5.12M
9.25%
-14.09K
-0.27%
Mar 31, 2025
BlackRock Institutional Trust Company, N.A.
3.45M
6.24%
-11.08K
-0.32%
Mar 31, 2025
AllianceBernstein L.P.
2.14M
3.87%
+391.21K
+22.32%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
1.42M
2.56%
+429.46K
+43.56%
Mar 31, 2025
State Street Global Advisors (US)
1.19M
2.15%
-1.44K
-0.12%
Mar 31, 2025
Geode Capital Management, L.L.C.
1.18M
2.14%
+19.63K
+1.69%
Mar 31, 2025
Loomis, Sayles & Company, L.P.
1.18M
2.14%
-25.76K
-2.13%
Mar 31, 2025
T. Rowe Price Associates, Inc.
1.01M
1.83%
+334.20K
+49.20%
Mar 31, 2025
Wellington Management Company, LLP
962.24K
1.74%
-528.72K
-35.46%
Mar 31, 2025
Ver más
ETFs relacionados
Actualizado: dom., 6 de jul
Actualizado: dom., 6 de jul
Nombre
Proporción
Global X HealthTech ETF
3.11%
SPDR S&P Health Care Equipment ETF
1.67%
Global X Robotics & Artificial Intelligence ETF
1.37%
Harbor Health Care ETF
1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
1.17%
ALPS Disruptive Technologies ETF
0.95%
Langar Global HealthTech ETF
0.86%
Main Thematic Innovation ETF
0.5%
BNY Mellon Innovators ETF
0.43%
Nuveen ESG Small-Cap ETF
0.37%
Ver más
Global X HealthTech ETF
Proporción3.11%
SPDR S&P Health Care Equipment ETF
Proporción1.67%
Global X Robotics & Artificial Intelligence ETF
Proporción1.37%
Harbor Health Care ETF
Proporción1.19%
First Trust Nasdaq Lux Digi Health Solutions ETF
Proporción1.17%
ALPS Disruptive Technologies ETF
Proporción0.95%
Langar Global HealthTech ETF
Proporción0.86%
Main Thematic Innovation ETF
Proporción0.5%
BNY Mellon Innovators ETF
Proporción0.43%
Nuveen ESG Small-Cap ETF
Proporción0.37%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Tipo
Relación
Sin datos
Fecha
Tipo
Relación
Sin datos
